PRCM
WST icon

Pine River Capital Management’s West Pharmaceutical WST Stock Holding History

Pine River Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,100
Closed -$517K – 350
2016
Q4 		$517K Buy
+6,100
New +$480K 0.02% 266

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Pine River Capital Management's WST Position: Q1 2017 in Review

Pine River Capital Management sold out of West Pharmaceutical (WST) in Q1 2017, closing a stake of 6,100 shares — an estimated $517K sold.

Pine River Capital Management first reported a position in WST in Q4 2016 and held it in 1 quarter. The position peaked at $517K in Q4 2016. 294 funds tracked by Wall St. Rank hold WST as of Q1 2017.

  • Pine River Capital Management reported no remaining West Pharmaceutical position as of Q1 2017 after selling out during the quarter.
  • Pine River Capital Management sold 6,100 West Pharmaceutical shares in Q1 2017, an estimated $517K.
  • Pine River Capital Management first reported a position in West Pharmaceutical in Q4 2016 and held it in 1 quarter.
  • Pine River Capital Management's West Pharmaceutical position peaked at $517K in Q4 2016.
  • 294 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2017.

Based on Pine River Capital Management's 13F filing for Q1 2017, filed 15 May 2017.